Hyperuricemia and the metabolic syndrome in Hangzhou;Chinese Source

Asia Pacific Journal of Clinical Nutrition

Volumn 18, Issue 1, 2009, Pages 81-87

  Cai, Zhenzhen ^a,b   Xu, Xiaofeng ^c   Wu, Xiangming ^d   Zhou, Ciqin ^a   Li, Duo ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c Convalescent Hospital ^*  (China)

^d NUOTE Nutrition Center   (China)

Author keywords

China; Correlation; Hangzhou; The metabolic syndrome; Uric acid

Indexed keywords

LIPID; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CHINA; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERURICEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERURICEMIA; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX FACTORS; URIC ACID; YOUNG ADULT;

EID: 67649973735     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li XY, Hu FB. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol. 2006;47:1588-94.
2. Sundström J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45:28-33.
3. Li D, Yu XM, Zhou XQ, Zhang YH, Zhang TZ, Sinclair AJ. Blood pressure status in Hangzhou region. Asia Pac J Clin Nutr. 2003;12 Suppl: S53.
4. Nan HR, Dong YH, Gao WG, Tuomilehto J, Qiao Q. Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract. 2007;76:68-74.
5. Nan HR, Qiao Q, Soderberg S, Pitkaniemi J, Zimmet P, Shaw J et al. Serum uric acid and incident diabetes in Mauritian and Creole populations. Diabetes Res Clin Pract. 2008; 80:321-7.
6. Ogura T, Matsuura, Matsumoto Y, Mimura Y, Kishida M, Otsuka F, Tobe K. Recent trend of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002. Metabolism. 2004;53: 448-53.
7. Johnson RJ, Gaucher EA, Sautin YY, Henderson GN, Angerhofer AJ, Benner SA. The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease. Med Hypotheses. 2008; 71:22-31.
8. Chen LK, Lin MH, Lai HY, Hwang SJ, Chiou ST. Uric acid: a surrogate of insulin resistance in older women. Maturitas. 2008;59:55-61.
9. Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004;148:635-40.
10. Li D, Yu XM, Zhou XQ, Siriamornpun S, Wahlqvist ML. Uric acid status and its correlates in Hangzhou urban population. Asia Pac J Clin Nutr. 2006;15:102-6.
11. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis. 2005;183:147-55.
12. Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clinica Chimica Acta. 2008;392:1-7.
13. Shankar A, Klein BEK, Nieto FJ, Klein R. Association between serum uric acid level and peripheral arterial disease. Atherosclerosis. 2008;196:749-55.
14. Ruggiero C, Cherubini A, Ble A, Bos AJG, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L. Uric acid and inflammatory markers. Eur Heart J. 2006;27:117-481.
15. Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk. Nutr Metab Cardiovasc Dis. 2007;17: 409-14.
16. Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, Sezgin N, Muderrisoglu H. Relationship of serum uric acid to measure of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract. 2005;59:1276-82.
17. Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of hyperuriceamia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res. 2006;37:883-9.
18. Sui XM, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008;57:845-52.
19. Numata T, Miyatake N, Wada J, Makino H. Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. Diabetes Res Clin Pract. 2008;80:e1-e5.
20. Reimann M, Schutte AE, Malan L, Huisman HW, Malan NT. Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population: A factor analysis. Atherosclerosis. 2008;197:638-45.
21. Expert Panel on Metabolic syndrome of Chinese Diabetes Society. Recommendations on Metabolic syndrome of Chinese Diabetes Society (in Chinese). Chin J Diab. 2004;12: 156-61.
22. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Survey. JAMA. 2000;283:2404-10.
23. Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H. Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J Epidemiol. 1997;26:288-96.
24. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health. 2004;4: 9-17.
25. Li ZY, Xu GB, Xia TA. Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing. Atherosclerosis. 2006;184:188-92.
26. Yang FY, Wahlqvist ML, Lee MS. Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002. Asia Pac J Clin Nutr. 2008;17:339-51.
27. Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T. Reduction of serum uric acid by hormone replacement therapy in post menopausal women with hyperuricaemia. Lancet. 1999;354:650-2.
28. Gu DF, Reynolds K, Wu XG, Chen J, Duan XF, Reynolds RF, Whelton PK, He J. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005; 365:1398-405.
29. Lee MS, Wahlqvist ML, Yu HL, Pan WH. Hyperuricemia and metabolic syndrome in Taiwanese children. Asia Pac J Clin Nutr. 2007;16 Suppl 2:594-600.
30. Lee MS, Lin SC, Chang HY, Lyu LC, Tsai KS, Pan WH. High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr. 2005;14: 285-92.
31. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biological parameters in a biracial population of Fiji. Am J Epidemiol. 1988;127:321-36.
32. Lin KC, Tsai ST, Lin HY, Chou P. Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the Kinmen study. J Rheumatol. 2004;31:1159-65.
33. Herman JB, Goldbourt U. Uric acid and diabetes: observations in a population study. Lancet. 1982;2:240-3.
34. Hayden MR, Tyagi SC. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab. 2004;1:10-24.
35. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sánchez-Lozada LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007; 86:899-906.